Incorporating sTILs Into PREDICT Substantially Improves the Model’s Ability to Distinguish High- and Low-Risk Patients with TNBC By Ogkologos - May 5, 2026 74 0 Facebook Twitter Google+ Pinterest WhatsApp Building the PREDICT_sTILs prognostication model Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Two Separate Indications for fam-Trastuzumab Deruxtecan-nxki in HER2-Positive Early-Stage Breast Cancer ESMO Calls for Further EU Measures Enhancing Europe’s Clinical Trial Regulatory Ecosystem Following Meeting of Health Ministers on 16 June 2026 ESMO Responds to Public Consultation on EU4Health Work Programme for 2027 and Highlights the Importance of Continuing Robust EU Support for Europe’s Beating Cancer... MOST POPULAR Man Spent 20 Years Tracking Down And Buying His Late Mother’s... October 30, 2021 Alcohol Tied to 750,000 Cancer Cases Worldwide in 2020 August 12, 2021 FDA Approves Selinexor for Refractory or Relapsed Multiple Myeloma January 8, 2021 Bride Cancels Engagement Photos To Share Special Dance With Terminal Dad. April 19, 2019 Load more HOT NEWS Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with... How Genomic Testing Brought Me a Sense of Control During Metastatic... Rebuilding My Life After Cancer and Intensive Treatment: A Survivor’s Story EMA Recommends Granting a Marketing Authorisation for Azacitidine
